Search Browse Earnings

Olema Pharmaceuticals, Inc.

Nasdaq:OLMA

Pharmaceutical Preparations·SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Olema Pharmaceuticals, Inc. — SlamSEC

Revenue

—

Adj. EBITDA

-$104.6M

FY 2024

Net Income

-$96.7M

FY 2024

EPS (Diluted)

-$2.14

FY 2024

Stock Price

$21.56

-4.4%

2026-03-06

52W Range

$2.86 – $36.26

P/E Ratio

-10.1x

Market Cap

$1.5B

Cash

$68.5M

FY 2024

Total Debt

—

Net Cash

$68.5M

Enterprise Value

$1.4B

Debt / EBITDA

0.7x

FY 2024

EV / EBITDA

-13.5x

Employees

—